RESUMEN
UNLABELLED: The aim of the study is to find the correlation between bone turnover markers and bone mineral density in a cohort of Moroccan postmenopausal women. PATIENTS AND METHODS: A cross-sectional study, conducted over a period of 12 months from October 2008 to November 2009. Five hundred Moroccan postmenopausal women volunteers participated in this study and we included only 185. RESULTS: In this cohort of 185 women, average age 60 years, the percentage of osteoporotic women was 35.7%, they were older 62.09 (9.13) years and they had an average of the body mass index (BMI), the lowest 29.58 (4.45). The values of the bone mineral density (BMD) measured at the lumbar spine correlated positively and significantly with BMI (P<0.001), serum calcium (P=0.026), negatively with age (P<0.001) and osteocalcin (OC) (P=0.0033). As for the results of BMD measured at the femoral neck, they show a negative and highly significant correlation with age (P<0.001) and osteocalcin. Looking for an association between the biochemical markers of bone remodeling, a weak positive correlation was found between the calcium (Ca) and alkaline phosphatase (PAL) on the one hand and Ca and intact parathyroid hormone (PTHi) in the other hand. And a significant positive correlation was found between PTHi and PAL, and between PTHi and OC. Finally, a significant positive correlation was found between the cross-laps (ß-CTX) and Ca and between PAL and OC. CONCLUSION: Our results are in agree to some international studies and disagree to others.
Asunto(s)
Fosfatasa Alcalina/sangre , Densidad Ósea , Remodelación Ósea/fisiología , Calcio/sangre , Osteocalcina/sangre , Osteoporosis Posmenopáusica/sangre , Hormona Paratiroidea/sangre , Fósforo/sangre , Posmenopausia/sangre , Vitamina D/sangre , Anciano , Enfermedades Asintomáticas , Biomarcadores , Índice de Masa Corporal , Estudios Transversales , Femenino , Cuello Femoral/química , Cuello Femoral/diagnóstico por imagen , Humanos , Vértebras Lumbares/química , Vértebras Lumbares/diagnóstico por imagen , Persona de Mediana Edad , Marruecos/epidemiología , Osteoporosis Posmenopáusica/epidemiología , Radiografía , Vitamina D/fisiologíaRESUMEN
This study was conducted to clarify the effect of ingesting soy isoflavone extracts (not soy protein or foods containing isoflavones) on bone mineral density (BMD) in menopausal women. PubMed, CENTRAL, ICHUSHI, CNKI, Wanfang Data, CQVIP, and NSTL were searched for randomized controlled trials published in English, Japanese, or Chinese reporting the effects of soy isoflavone extracts on lumbar spine or hip BMD in menopausal women. Trials were identified and reviewed for inclusion and exclusion eligibility. Data on study design, participants, interventions, and outcomes were extracted. Eleven, seven, five, and five trials were finally selected for estimation of the effects on spine, femoral neck, hip total, and trochanter BMD, respectively. Meta-analysis including data from1240 menopausal women revealed that daily ingestion of an average of 82 (47-150) mg soy isoflavones (aglycone equivalent) for 6-12 months significantly increased spine BMD by 22.25 mg/cm2 (95% CI: 7.62, 32.89; p=0.002), or by 2.38% (95% CI: 0.93, 3.83; p=0.001) compared with controls (random-effects model). Subgroup analyses indicated that the varying effects of isoflavones on spine BMD across trials might be associated with study characteristics of intervention duration (6 vs. 12 months), region of participant (Asian vs. Western), and basal BMD (normal bone mass vs. osteopenia or osteoporosis). No significant effects on femoral neck, hip total, and trochanter BMD were found. Soy isoflavone extract supplements increased lumbar spine BMD in menopausal women. Further studies are needed to address factors affecting the magnitudes of effect on spine and to verify the effect on hip.
Asunto(s)
Densidad Ósea , Suplementos Dietéticos , Glycine max/química , Isoflavonas/uso terapéutico , Osteoporosis Posmenopáusica/prevención & control , Perimenopausia , Fitoterapia , Absorciometría de Fotón , Enfermedades Óseas Metabólicas/prevención & control , Enfermedades Óseas Metabólicas/terapia , Suplementos Dietéticos/efectos adversos , Femenino , Fémur/química , Cuello Femoral/química , Cadera , Humanos , Isoflavonas/efectos adversos , Vértebras Lumbares/química , Persona de Mediana Edad , Osteoporosis Posmenopáusica/terapia , Huesos Pélvicos/química , Fitoterapia/efectos adversos , Extractos Vegetales/efectos adversos , Extractos Vegetales/uso terapéutico , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
The efficacy and safety of intravenous ibandronate were evaluated in postmenopausal osteoporosis women in China. In this multicenter, positive drug-controlled study, 158 postmenopausal osteoporotic women were randomized to receive 2 mg ibandronate given intravenously once every 3 months or 70 mg alendronate given orally once per week. All women also received supplemental calcium (500 mg) and vitamin D (200 IU) daily. One hundred fifty-one patients completed the 1-year study. Ibandronate produced mean increases in bone mineral density (BMD) by 4.27% at the lumbar spine, 3.48% at the femoral neck, and 2.03% at the trochanter. Mean increases in BMD by 4.24% at the lumbar spine, 2.72% at the femoral neck, and 2.99% at the trochanter were observed in the alendronate group. No significant difference was found between the two groups in BMD in all sites measured. Significant decreases in serum c-telopeptide of type I collagen (CTX) and alkaline phosphatase (ALP) were found in the two groups after 1 and 3 months of treatment, respectively; these serum CTX and ALP levels were then maintained at the decreased levels throughout the study period (12 months). No changes of stature were found in the patients of the two groups. Adverse events were similar in the two groups, except more mild muscle pain was observed in the first month after infusion of ibandronate than with oral alendronate (P < 0.001). The results observed in Chinese patients may support the observation that intravenous ibandronate significantly reduced bone resorption and increased BMD with good tolerance in Chinese postmenopausal osteoporotic women. Use of intravenous ibandronate possibly could potentially improve compliance as compared with other oral bisphosphonates because it may avoid the peptic side effects of oral bisphosphonate.
Asunto(s)
Conservadores de la Densidad Ósea/uso terapéutico , Densidad Ósea/efectos de los fármacos , Resorción Ósea/sangre , Difosfonatos/uso terapéutico , Osteoporosis Posmenopáusica/tratamiento farmacológico , Anciano , Fosfatasa Alcalina/sangre , Biomarcadores/sangre , Estatura , Conservadores de la Densidad Ósea/administración & dosificación , Conservadores de la Densidad Ósea/efectos adversos , China , Colágeno Tipo I/sangre , Difosfonatos/administración & dosificación , Difosfonatos/efectos adversos , Femenino , Fémur/química , Cuello Femoral/química , Humanos , Ácido Ibandrónico , Infusiones Intravenosas , Vértebras Lumbares/química , Persona de Mediana Edad , Enfermedades Musculares/inducido químicamente , Osteoporosis Posmenopáusica/sangre , Dolor/inducido químicamente , Péptidos/sangre , Factores de TiempoRESUMEN
Bone disease with osteoporosis and osteomalacia are common in sickle cell disease (SCD). Some patients have vitamin D deficiency and low bone mineral density (BMD). The role of vitamin D and calcium supplementation to restore bone health in SCD has not been well studied. In 14 adults with SCD, we measured 25(OH)D (25-hydroxyvitamin D) and BMD at the femoral neck, lumbar spine, and distal third of the ulna plus radius, along with markers of bone resorption (CTx; C-terminal component of pro-collagen type I) and bone formation (osteocalcin) before and after 12 months of vitamin D(2) and calcium carbonate treatment. Pretreatment, all patients were vitamin D deficient with a mean 25(OH)D level of 11.6 [corrected] +/- 4 [corrected] ng/ml, had low BMD at the lumbar spine (L-spine), 0.87 +/- 0.11 g/cm(2) (mean Z-score of -2.6 3 +/- 0.71 SD and T score of -2.31 +/- 0.75 SD), femoral neck, 0.8 +/- 0.18 g/cm(2) (mean Z-score -1.36 +/- 0.84, T-score -1.14 +/- 0.75), and the distal radius and ulna, 0.6 +/- 0.17 g/cm(2) (mean Z-score -1.18 +/- 0.79, T-score -1.01 +/- 0.74) and had elevated CTx (0.87 +/- 0.5 ng/ml) and osteocalcin levels (12.3 +/- 3.7 ng/mul). After treatment, all patients corrected their 25(OH)D level (34.6 [corrected] +/- 11 [corrected] ng/ml) (P < 0.001) with a 3.6% +/- 3.9% increase in BMD at the L-spine (P = 0.009), 4.6% +/- 8.5% increase at the femoral neck (P = 0.05) and 6.5% +/- 12.6% increase at the distal radius plus ulna (P = 0.09). CTx, osteocalcin, and PTH(i) levels were unchanged. Treatment of adult SCD with vitamin D and calcium can restore 25(OH)D levels to normal and improve BMD, but, markers of bone resorption remained unchanged. Screening for vitamin D deficiency and BMD in SCD patients seems warranted.
Asunto(s)
Anemia de Células Falciformes/complicaciones , Resorción Ósea/tratamiento farmacológico , Carbonato de Calcio/uso terapéutico , Ergocalciferoles/uso terapéutico , Osteomalacia/tratamiento farmacológico , Osteoporosis/tratamiento farmacológico , Deficiencia de Vitamina D/tratamiento farmacológico , Adulto , Anemia de Células Falciformes/sangre , Densidad Ósea , Resorción Ósea/sangre , Resorción Ósea/etiología , Carbonato de Calcio/administración & dosificación , Colágeno Tipo I/sangre , Quimioterapia Combinada , Ergocalciferoles/administración & dosificación , Cuello Femoral/química , Humanos , Vértebras Lumbares/química , Osteocalcina/sangre , Osteomalacia/sangre , Osteomalacia/etiología , Osteoporosis/sangre , Osteoporosis/etiología , Hormona Paratiroidea/sangre , Péptidos/sangre , Proyectos Piloto , Vitamina D/análogos & derivados , Vitamina D/sangre , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/complicacionesRESUMEN
BACKGROUND: A previous study on a randomized controlled trial in 173 postmenopausal Chinese women in Kuala Lumpur showed that milk supplementation was effective to reduce bone loss at the total body, lumbar spine, femoral neck and total hip compared to the control group on a usual diet (Chee et al. 2003). OBJECTIVE: The objective was to determine whether the results were sustained after the conclusion of the study. DESIGN: A follow-up study, 18 months after a randomized controlled trial of milk supplementation was concluded. A total of 139 participants were followed up 21 months after the study ended. Bone mineral density (BMD) was measured at the total body, lumbar spine, femoral neck and total hip by dual energy X-ray absorptiometry, and anthropometric measurements as well as changes in dietary habits were measured. RESULTS: At the follow-up, the milk supplement group did not show significant bone loss from baseline at most sites (mean differences +/- SE) (total body 0.42 +/- 0.25%, femoral neck 0.44 +/- 0.58%, total hip -0.06 +/- 0.46%), unlike the control group (total body -1.07 +/- 0.28% p < 0.005, femoral neck -1.49 +/- 0.56% p < 0.05, total hip -0.89 +/- 0.57% p < 0.05). However, both the milk and control groups showed bone loss from baseline at the lumbar spine (milk -2.01%, control -3.29%, p superior 0.05). The calcium intake of the milk group remained significantly higher than the control group (milk 710 mg/day, control 466 mg/day, p < 0.005) despite discontinuation of the milk supplement. CONCLUSIONS: The results showed that some of the beneficial effects of a milk supplement were still evident at follow-up and it was possible to motivate subjects to adopt a positive change in dietary calcium intake after intervention.
Asunto(s)
Conservadores de la Densidad Ósea/farmacología , Densidad Ósea/efectos de los fármacos , Calcio de la Dieta/farmacología , Leche , Osteoporosis Posmenopáusica/tratamiento farmacológico , Anciano , Animales , Conservadores de la Densidad Ósea/administración & dosificación , Calcio de la Dieta/administración & dosificación , Bovinos , China/etnología , Femenino , Cuello Femoral/química , Estudios de Seguimiento , Humanos , Vértebras Lumbares/química , Malasia , Persona de Mediana Edad , Osteoporosis Posmenopáusica/prevención & control , Resultado del TratamientoRESUMEN
The collagen fibril diameter was measured in cortical bone samples from the femoral neck, rear and front tibia of female and male rats and rabbits using electron microscopy analysis. In most cases, statistically significant differences in mean fibril diameter values between different bone sites were detected. The order of magnitude for the above structural parameter was the same for both genders in both experimental species. In rats, the greatest mean diameter value was that for the femoral, while in rabbits, the one for the rear tibia demonstrating a dependence on bone use and life style. An important aspect was the agreement between these observations and the mean values for Ca/P ratio, as observed in previous experiments, in the same bone sites and animals. Collagen fibril diameter and Ca/P ratio can both serve as indexes of bone quality.
Asunto(s)
Huesos/química , Colágeno/ultraestructura , Animales , Calcio/análisis , Femenino , Cuello Femoral/química , Masculino , Microscopía Electrónica , Fósforo/análisis , Conejos , Ratas , Ratas Wistar , Tibia/químicaRESUMEN
Based on the present definition of osteoporosis, both bone density and quality are important factors in the determination of bone strength. Collagen crosslinking is a determinant of bone quality. Cross-links can form enzymatically by the action of lysyl oxidase or non-enzymatically, resulting in advanced glycation end products. Collagen crosslinking is affected by tissue maturation as well as the degree of mineralization. Homocysteine and vitamin B6 (pyridoxal) are also regulatory factors of collagen crosslinking. We elucidate the relationship between the degree of mineralization and collagen cross-links in cancellous bone from hip fracture cases. We also determined plasma levels of homocysteine and pyridoxal. Twenty-five female intracapsular hip fracture cases (78 +/- 6 years) and 25 age-matched postmortem controls (77 +/- 6 years) were included in this study. Collagen crosslinking was analyzed after each bone specimen was fractionated into low (1.7-2.0 g/ml) and high (>2.0 g/ml) density fractions. The content of enzymatic (immature reducible and mature nonreducible cross-links) and nonenzymatic cross-link (pentosidine) were determined. In the controls, there was no difference in total enzymatic cross-links between low and high density bone, while pentosidine content was significantly higher in high density bone. In the fracture cases, not only reduced enzymatic cross-links in high density bone and increased pentosidine in both low and high density bone, but also higher plasma homocysteine and lower pyridoxal levels were evident compared with the controls. These results indicate that detrimental crosslinking in both low and high mineralized bone result in impaired bone quality in osteoporotic patients.
Asunto(s)
Calcificación Fisiológica , Colágeno/metabolismo , Cuello Femoral/fisiología , Fracturas de Cadera/etiología , Osteoporosis/fisiopatología , Absorciometría de Fotón , Anciano , Anciano de 80 o más Años , Calcio/análisis , Femenino , Cuello Femoral/química , Homocisteína/sangre , Humanos , Osteoporosis/complicaciones , Fósforo/análisis , Espectrofotometría Atómica , Vitamina B 6/sangreRESUMEN
The Ca/P ratio was measured in cortical bone samples from the femoral neck, front and rear tibia of female rats (1.5 years of age), using synchrotron radiation microtomography. The use of a monoenergetic x-ray beam, as provided by the synchrotron facility, generates accurate 3D maps of the linear attenuation coefficient within the sample and hence gives the ability to map different chemical components. Data sets were taken at 20 keV for each bone sample and calibration phantoms. From the 3D data sets, multiple 2D slices were reconstructed with a slice thickness of approximately 28 microm and converted to Ca/P ratios using the calibration phantom results. Mean values (M +/- SD) for cortical femoral, front and rear tibias are 2.12 +/- 0.08, 1.75 +/- 0.06 and 1.94 +/- 0.07 respectively. These values were compared with those derived from different animals. Differences between the same bone sites from different animals are not significant (0.1 < p < or = 0.9) while those between different bone sites are highly significant (p < 10(-3)) demonstrating a dependence upon life style and bone use.
Asunto(s)
Huesos/química , Calcio/química , Fantasmas de Imagen , Fósforo/química , Sincrotrones , Animales , Densidad Ósea , Huesos/diagnóstico por imagen , Femenino , Cuello Femoral/química , Cuello Femoral/diagnóstico por imagen , Ratas , Ratas Wistar , Tibia/química , Tibia/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
Auger electron spectroscopy was used to detect calcium and phosphorus of cortical bone from rat femoral neck and rear tibia. Spectra were taken from bone pieces as well as from disks prepared from grinded bone material. Experimental conditions were found whereby the samples could be analyzed without conductive coatings. The results of this preliminary investigation demonstrate that Auger electron spectroscopy can be used to study bone mineral elements.
Asunto(s)
Huesos/química , Calcio/análisis , Fósforo/análisis , Análisis Espectral/métodos , Animales , Cuello Femoral/química , Masculino , Ratas , Ratas Wistar , Sincrotrones , Tibia/químicaRESUMEN
The Ca/P ratio was measured in cortical bone samples from the femoral neck and tibia of different animal species, using synchrotron radiation microtomography. Use of a monoenergetic X-ray beam, as provided by the synchrotron facility, generates accurate 3D maps of the linear attenuation coefficient within the sample and hence gives the ability to map different chemical components. Also, by comparing normal and abnormal bones, i.e. osteoporotic (induced by inflammation), changes in the Ca/P ratio brought about by bone diseases can be detected. MicroCT data sets were collected at 20 and 28 keV for each bone sample and two calibration phantoms. From the 3D data sets, multiple 2D slices were reconstructed with a slice thickness of approximately 30 microm. Regions of interest were defined around suitable sites and were converted to Ca/P ratios using the data collected from the test phantoms. A significant difference (p<0.001) between osteoporotics and age-matched normals at both energies was detected. Differences between different bone sites from the same animal are not significant (p>0.5) while those between the same bone sites from different animals are highly significant (p<0.001). Differences between estimates made at 20 and 28 keV are not significant (p>0.5). An important aspect is the ability to map the spatial distribution of the Ca/P ratio.
Asunto(s)
Densidad Ósea/fisiología , Huesos/química , Calcio/análisis , Fósforo/análisis , Tomografía Computarizada por Rayos X/métodos , Animales , Huesos/metabolismo , Huesos/fisiología , Femenino , Cuello Femoral/química , Cuello Femoral/metabolismo , Cuello Femoral/fisiología , Imagenología Tridimensional/métodos , Masculino , Osteoporosis/metabolismo , Conejos , Intensificación de Imagen Radiográfica/métodos , Ovinos , Sincrotrones , Tibia/química , Tibia/metabolismo , Tibia/fisiologíaRESUMEN
UNLABELLED: Bone metabolism follows a seasonal pattern with high bone turnover and bone loss during the winter. In a randomized, open-label 2-year sequential follow-up study of 55 healthy adults, we found that supplementation with oral vitamin D3 and calcium during winter abolished seasonal changes in calciotropic hormones and markers of bone turnover and led to an increase in BMD. Supplementation with oral vitamin D3 and calcium during the winter months seems to counteract the effects of seasonal changes in vitamin D and thus may be beneficial as a primary prevention strategy for age-related bone loss. INTRODUCTION: Bone metabolism follows a seasonal pattern characterized by high bone turnover and bone loss during winter. We investigated whether wintertime supplementation with oral vitamin D3 and calcium had beneficial effects on the circannual changes in bone turnover and bone mass. MATERIALS AND METHODS: This prospective study comprised an initial observation period of 12 months ("year 1"), followed by an intervention during parts of year 2. Fifty-five healthy subjects living in southwestern Germany (latitude, 49.5 degrees N) were randomized into two groups: 30 subjects were assigned to the treatment group and received oral cholecalciferol (500 IU/day) and calcium (500 mg/day) during the winter months of year 2 (October-April), while 25 subjects assigned to the control group obtained no supplements. Primary endpoints were changes in calciotropic hormones [serum 25(OH)D, 1,25(OH)2D, and parathyroid hormone], markers of bone formation (serum bone-specific alkaline phosphatase) and of bone resorption (urinary pyridinoline and deoxypyridinoline), and changes in lumbar spine and femoral neck BMD. RESULTS: Forty-three subjects completed the study. During year 1, calciotropic hormones, markers of bone turnover, and BMD varied by season in both groups. During the winter months of year 1, bone turnover was significantly accelerated, and lumbar spine and femoral BMD declined by 0.3-0.9%. In year 2, seasonal changes in calciotropic hormones and markers of bone turnover were either reversed or abolished in the intervention group while unchanged in the control cohort. In the subjects receiving oral vitamin D3 and calcium, lumbar and femoral BMD increased significantly (lumbar spine: +0.8%, p = 0.04 versus year 1; femoral neck: +0.1%, p = 0.05 versus year 1), whereas controls continued to lose bone (intervention group versus control group: lumbar spine, p = 0.03; femoral neck, p = 0.05). CONCLUSIONS: Supplementation with oral vitamin D3 and calcium during winter prevents seasonal changes in bone turnover and bone loss in healthy adults. It seems conceivable that annually recurring cycles of low vitamin D and mild secondary hyperparathyroidism during the winter months contributes, at least in part and over many years, to age-related bone loss. Supplementation with low-dose oral vitamin D3 and calcium during winter may be an efficient and inexpensive strategy for the primary prevention of bone loss in northern latitudes.
Asunto(s)
Resorción Ósea/prevención & control , Calcio/farmacología , Colecalciferol/farmacología , Suplementos Dietéticos , Osteoporosis/prevención & control , Estaciones del Año , Vitamina D/análogos & derivados , Absorciometría de Fotón , Adulto , Anciano , Fosfatasa Alcalina/sangre , Fosfatasa Alcalina/metabolismo , Aminoácidos/metabolismo , Aminoácidos/orina , Densidad Ósea/efectos de los fármacos , Resorción Ósea/tratamiento farmacológico , Huesos/efectos de los fármacos , Huesos/enzimología , Huesos/metabolismo , Calcio/administración & dosificación , Calcio/sangre , Colecalciferol/administración & dosificación , Femenino , Cuello Femoral/química , Humanos , Vértebras Lumbares/química , Masculino , Persona de Mediana Edad , Osteoporosis/tratamiento farmacológico , Hormona Paratiroidea/sangre , Hormona Paratiroidea/metabolismo , Estudios Prospectivos , Resultado del Tratamiento , Vitamina D/sangre , Vitamina D/metabolismoRESUMEN
The Ca and P concentrations as well as the Ca/P ratio were estimated in intact trabecular bone samples from the femoral neck of healthy humans, 34 women and 44 men, aged from 15 to 55 years, using instrumental neutron activation analysis. The mean values (M+/-SD) for the investigated parameters (on a dry-weight basis) were: 12.1+/-3.0%, 5.94+/-1.71%, 2.07+/-0.25 and 10.9+/-2.5%, 5.30+/-1.23%, 2.07+/-0.22 for females and males, respectively. A statistically significant (p=0.05) decrease of Ca concentration with age was found only for males while the P concentration and the Ca/P ratio were not affected by age. No statistically significant sex-related differences were observed in any of the parameters. The mean values for Ca, P and the Ca/P ratio lay close to the median of the very wide range of published data. The individual variation for the Ca/P ratio in trabecular bone from the healthy human femoral neck was lower than those for Ca and P separately. This suggests that the specificity of the Ca/P ratio is better than that of Ca and P concentrations and may be more reliable for the diagnosis of bone disorders.
Asunto(s)
Calcio/análisis , Cuello Femoral/química , Análisis de Activación de Neutrones/métodos , Fósforo/análisis , Adolescente , Adulto , Factores de Edad , Cadáver , Femenino , Humanos , Técnicas In Vitro , Masculino , Persona de Mediana Edad , Sensibilidad y Especificidad , Factores SexualesRESUMEN
Concentrations of Ca and P as well as the Ca/P ratio were estimated in intact cortical bone samples from the femoral neck of healthy humans, 33 women and 45 men, aged from 15 to 55 yr using instrumental neutron activation analysis. Mean values (M +/- SD) for the investigated parameters (on dry weight basis) were: 23.0 +/- 3.9%, 10.7 +/- 2.4% and 2.17 +/- 0.31, respectively. No statistically significant differences of the above parameters were observed related either to age or sex. The mean values for Ca, P and Ca/P ratio were within a very wide range of published data and close to their median. The individual variation for the Ca/P ratio in cortical bone from the healthy human femoral neck was lower than those for Ca and P separately. This means that specificity of Ca/P ratio is better than those of Ca and P concentrations are and may be more reliable for diagnosis of bone disorders.
Asunto(s)
Calcio/análisis , Cuello Femoral/química , Fósforo/análisis , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis de Activación de Neutrones/métodos , Valores de Referencia , Caracteres SexualesRESUMEN
BACKGROUND: Bone mineral density (BMD) is largely genetically determined and this influence is most powerful in the period of rapid skeletal development in childhood and late adolescence but environmental factors such as exercise and dietary calcium intake may influence up to 20%. AIMS OF THE STUDY: The aims of the study were to examine healthy late adolescent females for the effects and benefits of a high calcium intake from dairy product foods on bone mineral density, body composition, lipids and biochemistry. The secondary aim is determine whether a high intake of dairy product foods in the diet is acceptable for this age group long term. METHODS: Ninety-one teenage girls who participated in a two-year randomised controlled study on the effect of dairy food supplementation on dietary patterns, body composition and bone density in post-pubertal teenage girls were approached one year after the cessation of the study to determine the effects of the cessation of dairy supplements on bone mineral density, dietary habits, biochemical markers, body composition and blood lipids. Bone mineral density and bone mineral content were assessed at the hip, spine and total body. Anthropometric data were collected, and exercise, Tanner, dietary assessment, preference and compliance questionnaires were administered. Lipid profiles, hydroxyproline excretion and urinary calcium and sodium excretion measurements were performed. RESULTS: There were no significant differences between the 2 groups for height, weight, lean and fat mass. The supplemented group had significantly higher calcium, phosphorus and protein intake during the supplementation period (p < 0.001). No differences were seen between the groups 12 months after supplementation finished. There were no significant differences in exercise level, preference or acceptability of dairy products or in the lipids and bone markers between baseline the end of supplementation and 1 year follow-up. There was a significant increase in trochanter (4.6%), lumbar spine (1.5%) and femoral neck (4.8%) BMD (p < 0.05) in the high calcium group at the end of supplementation. There was an increase in bone mineral content at the trochanter (p < 0.05) and lumbar spine; however the latter was not statistically significant, in the high calcium group at the end of supplementation. There was no difference in vertebral height or width at any stage of the study, indicating no influence on bone size. CONCLUSIONS: In this 3 year study (2 years of supplementation, 1 year follow-up), teenage girls, aged 15-18 years, were able to significantly increase their BMD at the trochanter, femoral neck and lumbar spine when supplemented with dairy product foods to a mean calcium intake of 1160 mg/d. There was also an effect seen on the BMC particularly at the trochanter and to a lesser extent at the lumbar spine. The dietary calcium intake achieved did not adversely affect body weight, fat and lean mass or blood lipid profiles. Twelve months after the supplementation finished the girls had returned to their baseline diet, indicating self-selection of a high dairy product diet may be hard to achieve.